IMMX

Immix Biopharma Inc

Jun 02 • 02:05PM ET

8.42

-0.80 -8.68 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY KYMR NUVL BMRN RYTM VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC AVSC TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	24.07%	Shs Outstand	53.01M	Perf Week	-4.75%
Market Cap	458.14M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	0.01%	Shs Float	41.32M	Perf Month	-9.46%
Enterprise Value	368.60M	PEG	-	EPS next Q	-0.18	Inst Own	49.13%	Short Float	7.79%	Perf Quarter	3.31%
Income	-34.98M	P/S	-	EPS this Y	21.53%	Inst Trans	3.54%	Short Ratio	3.38	Perf Half Y	98.12%
Sales	0.00M	P/B	5.29	EPS next Y	7.28%	ROA	-60.47%	Short Interest	3.22M	Perf YTD	60.99%
Book/sh	1.59	P/C	5.06	EPS next 5Y	39.20%	ROE	-74.47%	52W High	11.61 -27.48%	Perf Year	223.85%
Cash/sh	1.66	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.87 350.27%	Perf 3Y	312.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.80% 8.66%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.26	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	-10.22%	Beta	0.11	Target Price	18.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-9.61%	Rel Volume	1.32	Prev Close	9.22
Employees	21	LT Debt/Eq	0.01	Earnings	Feb 25	SMA200	42.09%	Avg Volume	951.54K	Price	8.42
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-83.03% -	Trades		Volume	900,919	Change	-8.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)